MHRA Warns Against Illegal Weight-Loss Drugs Amid NHS Waitlists and Rising Obesity Rates

December 30, 2024
MHRA Warns Against Illegal Weight-Loss Drugs Amid NHS Waitlists and Rising Obesity Rates
  • The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a warning against acquiring illegal weight-loss medications without a prescription, particularly through dubious online platforms and beauty salons.

  • Purchasing unregulated drugs online poses significant health risks, as individuals miss out on essential medical support for obesity treatment.

  • The MHRA emphasizes the dangers of counterfeit products, cautioning against buying weight-loss drugs online or via social media without a prescription.

  • In response to the obesity crisis, the NHS plans to roll out the weight-loss drug Mounjaro over the next 12 years, aiming to benefit 220,000 people in the first three years, despite an estimated 3.4 million individuals being eligible.

  • Prof. Kamila Hawthorne has expressed concern over the rising population and the associated increase in chronic illnesses linked to obesity, urging the government to enhance funding for weight-loss services.

  • Patients are facing long waiting times for NHS support, with some waiting up to five years, which is driving them to consider self-medication as an alternative.

  • Approximately 15.8 million adults in the UK are classified as obese, representing 30% of the population, highlighting the urgent need for effective weight management solutions.

  • A spokesperson from the Department of Health and Social Care has emphasized that while weight-loss drugs can be beneficial, they should be used in conjunction with a healthy diet and exercise as part of a comprehensive health strategy.

  • Prof. Hawthorne warns that the long NHS waiting lists for weight-loss clinics are leading individuals to purchase unsafe fat jabs from unregulated sources.

  • Katharine Jenner, director of the Obesity Health Alliance, stresses that weight-loss drugs should only be used under medical supervision for those who truly need them.

  • The popularity of weight-loss drugs like Wegovy and Mounjaro has surged, fueled by celebrity endorsements and clinical trials, yet cheaper, unregulated alternatives are increasingly being prepared at home.

  • As the year ends, many people seek quick weight-loss solutions, increasing the risk of encountering counterfeit products, according to MHRA's Andy Morling.

Summary based on 2 sources


Get a daily email with more UK News stories

More Stories